Mineralys Therapeutics, Inc. - Common Stock (MLYS)

123 filings reported holding MLYS - Mineralys Therapeutics, Inc. - Common Stock as of Q4 2024.
Mineralys Therapeutics, Inc. - Common Stock (MLYS) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46.5M shares of 77.4M outstanding shares and own 60.07% of the company stock.
Largest 10 shareholders include Catalys Pacific, LLC (8.64M shares), Samsara BioCapital, LLC (5.07M shares), RA CAPITAL MANAGEMENT, L.P. (4.85M shares), TCG Crossover Management, LLC (2.47M shares), BlackRock, Inc. (2.14M shares), SR One Capital Management, LP (2.02M shares), FRANKLIN RESOURCES INC (1.75M shares), ORBIMED ADVISORS LLC (1.61M shares), VANGUARD GROUP INC (1.43M shares), and Laurion Capital Management LP (1.41M shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.